Literature DB >> 14749423

CRE-mediated transcription is increased in Huntington's disease transgenic mice.

Karl Obrietan1, Kari R Hoyt.   

Abstract

Disruption of cAMP response element (CRE)-dependent transcription has been hypothesized to contribute to neuronal death and dysfunction in Huntington's disease (HD) and other polyglutamine repeat disorders. Whether dysregulation of CRE-dependent transcription actually occurs in vivo in response to expression of expanded polyglutamine repeats has not been tested. We directly tested whether CRE-dependent transcription is affected in vivo by cross breeding a transgenic mouse model of HD (line R6/2) with a transgenic mouse that expresses a CRE-regulated reporter gene. Instead of compromised CRE-dependent transcription in HD mice, we found a robust upregulation of CRE-dependent transcription in several brain regions (striatum, hippocampus, cortex). CRE-mediated transcription was also evoked by striatal forskolin infusion and by photic stimulation in HD animals. Increased cAMP response element-binding protein (CREB) phosphorylation and elevated levels of the CREB-regulated gene product, CCAAT/enhancer binding protein beta, were also found in HD mice. Significant alterations in CREB binding protein expression and localization were not observed in symptomatic R6/2 mice. Thus, rather than repressing CRE-mediated transcription, mutant huntingtin appears to facilitate transcription via a CRE-dependent mechanism in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749423      PMCID: PMC6729812          DOI: 10.1523/JNEUROSCI.3493-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.

Authors:  Lianwu Fu; Ya-sheng Gao; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2005-06-16       Impact factor: 5.996

Review 2.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

3.  PLCgamma2 Activates CREB-dependent Transcription in PC12 Cells Through Phosphorylation of CREB at Serine 133.

Authors:  Taku Iwamoto; Nori Mamiya; Shoichi Masushige; Satoshi Kida
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

Review 4.  CREB: a multifaceted regulator of neuronal plasticity and protection.

Authors:  Kensuke Sakamoto; Kate Karelina; Karl Obrietan
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

5.  CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease.

Authors:  Yun-Sik Choi; Boyoung Lee; Hee-Yeon Cho; Iza B Reyes; Xin-An Pu; Takaomi C Saido; Kari R Hoyt; Karl Obrietan
Journal:  Neurobiol Dis       Date:  2009-07-24       Impact factor: 5.996

6.  Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction.

Authors:  Tomoyuki Yamanaka; Asako Tosaki; Haruko Miyazaki; Masaru Kurosawa; Yoshiaki Furukawa; Mizuki Yamada; Nobuyuki Nukina
Journal:  Hum Mol Genet       Date:  2010-02-25       Impact factor: 6.150

7.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

Review 8.  Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Authors:  Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

9.  Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor.

Authors:  Tomoyuki Yamanaka; Haruko Miyazaki; Fumitaka Oyama; Masaru Kurosawa; Chika Washizu; Hiroshi Doi; Nobuyuki Nukina
Journal:  EMBO J       Date:  2008-02-21       Impact factor: 11.598

10.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.